Editorial: Tofacitinib and Biologics for Moderate‐to‐severe Ulcerative Colitis—what is Best in Class?

H. H. Tsai

Alimentary Pharmacology &amp Therapeutics（2018）

Cited 5|Views2
No score
Abstract
Linked ContentThis article is linked to Bonovas et al papers. To view these articles visit https://doi.org/10.1111/apt.14449 and https://doi.org/10.1111/apt.14486.
More
Translated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined